Artemisinin Said Losing Effectiveness In Treating Southeast Asia Malaria
This article was originally published in PharmAsia News
Executive Summary
The main ingredient in malaria drugs relied on in Southeast Asia is reported to be losing its ability to stop the spread of the disease. A newly published study says artemisinin, the active pharmaceutical ingredient in anti-malaria drugs considered the most effective, now takes nearly twice as long as before to clean out the parasites behind the disease. Studies were carried out in Cambodia and Thailand. The decline in effectiveness is similar to that experienced for chloroquine and fansidar half a century ago. (Click here for more
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.